NeuCyte

Neu Cyte

Pharmaceuticals, 319 Bernardo Ave, Mountain View, California, 94043, United States, 11-50 Employees

neucyte.com

  • twitter
  • LinkedIn

phone no Phone Number: 65********

Who is NEUCYTE

The high attrition rates of novel drugs in clinical trials is a clear indication that current preclinical testing is failing to predict compounds that will reach the market. NeuCyte, is a...

Read More

map
  • 319 Bernardo Ave, Mountain View, California, 94043, United States Headquarters: 319 Bernardo Ave, Mountain View, California, 94043, United States
  • 2015 Date Founded: 2015
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $5 Million to $10 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 1731 | NAICS Code: 238210 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from NEUCYTE

NeuCyte Org Chart and Mapping

Employees

Hui Liu

Director of Drug Discovery

Ji Wu

VP of Business Development

Dominique Lessard

Head of Business Development

Angela Murchison

Scientist 2, Platform Development Lead

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding NeuCyte

Answer: NeuCyte's headquarters are located at 319 Bernardo Ave, Mountain View, California, 94043, United States

Answer: NeuCyte's phone number is 65********

Answer: NeuCyte's official website is https://neucyte.com

Answer: NeuCyte's revenue is $5 Million to $10 Million

Answer: NeuCyte's SIC: 1731

Answer: NeuCyte's NAICS: 238210

Answer: NeuCyte has 11-50 employees

Answer: NeuCyte is in Pharmaceuticals

Answer: NeuCyte contact info: Phone number: 65******** Website: https://neucyte.com

Answer: The high attrition rates of novel drugs in clinical trials is a clear indication that current preclinical testing is failing to predict compounds that will reach the market. NeuCyte, is an early-stage biotechnology company focused on advancing the drug discovery process by using cell based target-identification and drug-discovery platforms. Our technology accelerates the lead drug identification and optimization process. NeuCytes unique human neural platform allows for the evaluation of human specific neural phenotypes that are not identifiable in traditional animal models. This allows for a more reliable predictor of drug efficacy and potential neurotoxicity. NeuCytes all-star staff and scientific advisory board is comprised of some of the top stem cell biologists and neuroscientists in the world. The vast knowledge of our team gives us an unrivaled competitive advantage, which allows us to address the unmet needs of patients with neurological disorders.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access